BGM Group Ltd.

BGMSEC EDGAR

Pharmaceutical Preparations(E9)CIK: 1779578

Concept	FY2024	FY2023	FY2022	FY2021
Revenue from Contract with Customer, Excluding Assessed Tax	$64.9M	$57.1M	$50.0M	$46.1M
Cost of Revenue	$58.6M	$51.5M	$42.5M	$36.4M
Gross Profit	$6.2M	$5.6M	$7.5M	$9.7M
Research and Development Expense	$1.2M	$8.0K	$54.0K	$54.0K
Selling, General and Administrative Expense	—	—	$2.7M	$3.5M
Operating Income (Loss)	$2.1M	$2.4M	$4.8M	$6.2M
Interest Expense	—	—	—	$223.7K
Nonoperating Income (Expense)	-$541.4K	$975.2K	$994.2K	$763.4K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest

Concept	FY2024	FY2023	FY2022	FY2021
Assets	$51.3M	$64.5M	$75.4M	$48.1M
Assets, Current	$34.5M	$30.0M	$40.4M	$37.5M
Cash and Cash Equivalents, at Carrying Value	$7.5M	$14.3M	$10.5M	$11.9M
Accounts Receivable, after Allowance for Credit Loss, Current	$2.0M	$815.3K	$1.7M	$1.1M
Inventory, Net	$5.0M	$8.9M	$12.5M	$12.0M
Liabilities	$6.9M	$9.6M	$18.7M	$19.3M
Liabilities, Current	$6.7M	$9.2M	$18.2M	$18.4M
Accounts Payable, Current	$3.6M	$5.3M	$6.6M	$4.4M
Stockholders' Equity Attributable to Parent

Concept	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$12.7M	$345.0K	$5.1M	-$580.2K
Net Cash Provided by (Used in) Investing Activities	-$3.3M	-$24.2M	-$375.6K	-$800.2K
Net Cash Provided by (Used in) Financing Activities	-$5.9M	$24.0M	$2.1M	$507.2K
Payments to Acquire Property, Plant, and Equipment	$2.0M	$1.5M	$449.8K	$616.4K

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)